Proteus
Proteos Leadership Team
Robert L. Heinrikson, Ph.D.
Founder, Chief Scientific Officer and Chairman of the Board
Dr. Heinrikson is known internationally as one of the world's leading protein chemists. His career has been equally divided between academia and the pharmaceutical industry, with 18 years as Professor of Biochemistry at the University of Chicago and 19 years as Senior Research Scientist and Distinguished Fellow at Upjohn/Pharmacia in Kalamazoo, MI. He is on the editorial board of four journals in the field of biochemistry, with 20 years service as editor of the Journal of Biological Chemistry. Dr. Heinrikson's field of expertise is protein chemistry and protein structure-function relationships; he lists >200 peer-reviewed publications, review articles and book chapters.
Clark W. Smith, Ph.D.
Co-Founder, President and CEO
Dr. Smith's career spans 6 years in academia and 23 years at Upjohn/Pharmacia in Kalamazoo where he was Director of Protein Sciences and leader of the peptide synthesis group. From 1998-2003, Dr. Smith was Senior Director of Global Research Site Operations. His expertise is in peptide chemistry, and he is one of the founding officers of the American Peptide Society with >85 peer-reviewed publications.
George B. Gross
Vice President of Business Development businessdevel@proteos.net
Mr. Gross directs the sales and business development activities within Proteos. He brings 30 years of sales and marketing leadership from Upjohn/Pharmacia to the management team of Proteos.
Phillip G. Zaworski, M.S.
Head, Cell and Molecular Biology
Mr. Zaworski has over 18 years of industrial experience in the application of molecular biological and fermentation techniques towards the expression of proteins using bacterial, yeast, mammalian cell and insect cell expression systems.
Martin R. Deibel, Jr., Ph.D.
Head, Protein Expression and Purification
Dr. Deibel is an internationally recognized investigator in protein science. He had 19 years experience at Upjohn/Pharmacia in Kalamazoo in leading team efforts in production, purification, and assay development of key target proteins in a number of therapeutic areas. Dr. Deibel lists over 75 peer reviewed papers in protein science.